Botensilimab, Balstilimab and Regorafenib for the Treatment of Patients With Microsatellite Stable Metastatic Colorectal Cancer Who Have Progressed on Prior Chemotherapy
April 5, 2022
Niraparib and Panitumumab in Patients With Advanced or Metastatic Colorectal Cancer
